|
MPZL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.575600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.991900E-02 |
| Normal-vs-Stage2 |
4.322400E-01 |
| Normal-vs-Stage3 |
7.485000E-01 |
| Normal-vs-Stage4 |
7.641200E-01 |
| Stage1-vs-Stage2 |
2.975900E-02 |
| Stage1-vs-Stage3 |
9.383800E-02 |
| Stage1-vs-Stage4 |
1.567020E-01 |
| Stage2-vs-Stage3 |
2.524200E-01 |
| Stage2-vs-Stage4 |
3.028000E-01 |
| Stage3-vs-Stage4 |
9.987800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.586770E-01 |
| Normal-vs-AfricanAmerican |
1.573430E-01 |
| Normal-vs-Asian |
1.617210E-01 |
| Caucasian-vs-AfricanAmerican |
5.757800E-01 |
| Caucasian-vs-Asian |
5.177200E-01 |
| AfricanAmerican-vs-Asian |
9.823600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.530800E-01 |
| Normal-vs-Female |
6.878200E-02 |
| Male-vs-Female |
1.440430E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.088200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.903000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.739800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.261400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.481600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.543800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.318390E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.059200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.783000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.812800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.238300E-02 |
| Classical-VS-Follicular |
6.27786711504541E-12 |
| Classical-VS-Other |
8.363900E-02 |
| Classical-VS-Normal |
1.077640E-02 |
| Tall-VS-Follicular |
3.503500E-03 |
| Tall-VS-Other |
1.235560E-01 |
| Tall-VS-Normal |
7.037400E-01 |
| Follicular-VS-Other |
9.239200E-01 |
| Follicular-VS-Normal |
5.355100E-03 |
| Other-VS-Normal |
2.504400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.614000E-01 |
| Normal-vs-N1 |
1.894750E-01 |
| N0-vs-N1 |
9.290200E-02 |
|
|
